GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 362 filers reported holding GLOBUS MED INC in Q2 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $236 | -17.8% | 4,768 | -1.1% | 0.02% | -16.7% |
| Q2 2023 | $287 | +5.5% | 4,822 | +0.6% | 0.02% | 0.0% |
| Q1 2023 | $272 | -23.6% | 4,793 | 0.0% | 0.02% | -27.3% |
| Q4 2022 | $356 | -99.9% | 4,793 | +3.9% | 0.03% | +22.2% |
| Q3 2022 | $275,000 | +6.2% | 4,613 | 0.0% | 0.03% | +12.5% |
| Q2 2022 | $259,000 | -24.0% | 4,613 | 0.0% | 0.02% | -11.1% |
| Q1 2022 | $341,000 | +6.6% | 4,613 | +4.0% | 0.03% | +8.0% |
| Q4 2021 | $320,000 | -5.0% | 4,436 | +1.0% | 0.02% | -10.7% |
| Q3 2021 | $337,000 | -1.2% | 4,394 | -0.2% | 0.03% | +3.7% |
| Q2 2021 | $341,000 | +21.4% | 4,403 | -3.5% | 0.03% | +12.5% |
| Q1 2021 | $281,000 | +7.3% | 4,561 | +13.6% | 0.02% | -4.0% |
| Q4 2020 | $262,000 | +18.6% | 4,014 | -10.0% | 0.02% | +4.2% |
| Q3 2020 | $221,000 | +4.7% | 4,460 | -10.2% | 0.02% | -14.3% |
| Q1 2020 | $211,000 | – | 4,968 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sterling Investment Advisors, Ltd. | 277,723 | $14,197,000 | 7.25% |
| Consonance Capital Management LP | 1,313,177 | $67,130,000 | 6.64% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 938,900 | $47,997,000 | 4.30% |
| Next Capital Management LLC | 111,098 | $5,679,000 | 3.81% |
| Godshalk Welsh Capital Management, Inc. | 83,305 | $4,259,000 | 3.76% |
| Global Alpha Capital Management Ltd. | 317,650 | $16,238,000 | 2.81% |
| Pembroke Management, LTD | 369,575 | $18,893,000 | 2.06% |
| Van Berkom & Associates Inc. | 1,528,936 | $78,159,000 | 1.92% |
| NUANCE INVESTMENTS, LLC | 865,872 | $44,263,000 | 1.67% |
| Bridge City Capital, LLC | 57,031 | $2,915,000 | 1.26% |